Clover Biopharmaceuticals Ltd. (HK:2197) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Clover Biopharmaceuticals, Ltd. has scheduled a board meeting for August 27, 2024, to discuss and potentially approve their interim financial results and consider an interim dividend. This meeting will be critical for investors as it may impact the company’s stock performance based on the financial results and dividend decisions.
For further insights into HK:2197 stock, check out TipRanks’ Stock Analysis page.